Year-end report 1 January - 31 December 2023

Strong cash flow and significant actions to improve profitability within Medtech

Demand is healthy in the markets and segments where AddLife's companies operate. We can now summarize 2023 as a year...

Related Keywords

Stockholm ,Sweden ,Fredrik Dalborg ,Christina Rubenhag ,Addlife Youtube , ,Life Science ,Abuse Regulation ,Securities Markets ,Markets ,